UPL Ltd
UPL is principally engaged in the business of agrochemicals, industrial chemicals, chemical intermediates, speciality chemicals and production and sale of field crops and vegetable seeds.
- Market Cap ₹ 41,715 Cr.
- Current Price ₹ 556
- High / Low ₹ 625 / 448
- Stock P/E 515
- Book Value ₹ 102
- Dividend Yield 0.18 %
- ROCE 12.6 %
- ROE 16.6 %
- Face Value ₹ 2.00
Pros
- Company has delivered good profit growth of 26.7% CAGR over last 5 years
- Company has been maintaining a healthy dividend payout of 49.4%
Cons
- Stock is trading at 5.45 times its book value
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of -9.02% over past five years.
- Earnings include an other income of Rs.307 Cr.
- Company has high debtors of 152 days.
- Working capital days have increased from 37.9 days to 63.7 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Agro Chemicals Industry: Pesticides / Agrochemicals - Indian
Part of BSE 500 BSE 100 BSE 200 BSE Dollex 200 Nifty 500
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3,939 | 4,968 | 5,335 | 5,981 | 6,939 | 7,263 | 8,660 | 9,641 | 11,345 | 16,449 | 9,032 | 5,398 | 4,165 | |
3,513 | 4,303 | 4,793 | 5,143 | 5,996 | 6,314 | 7,821 | 8,436 | 9,725 | 14,392 | 8,178 | 4,996 | 3,966 | |
Operating Profit | 427 | 666 | 542 | 838 | 943 | 949 | 839 | 1,205 | 1,620 | 2,057 | 854 | 402 | 199 |
OPM % | 11% | 13% | 10% | 14% | 14% | 13% | 10% | 12% | 14% | 13% | 9% | 7% | 5% |
130 | 298 | 260 | 481 | 279 | 428 | 556 | 496 | 98 | 625 | 848 | 1,120 | 307 | |
Interest | 101 | 242 | 35 | 192 | 149 | 135 | 185 | 272 | 307 | 377 | 188 | 144 | 218 |
Depreciation | 158 | 169 | 187 | 619 | 655 | 666 | 724 | 891 | 977 | 1,044 | 431 | 130 | 125 |
Profit before tax | 297 | 552 | 581 | 508 | 418 | 576 | 486 | 538 | 434 | 1,261 | 1,083 | 1,248 | 163 |
Tax % | 30% | 25% | 20% | 24% | 41% | 5% | 17% | 14% | 49% | 7% | 10% | 3% | |
208 | 416 | 463 | 385 | 245 | 548 | 405 | 461 | 220 | 1,176 | 975 | 1,208 | 244 | |
EPS in Rs | 3.13 | 6.47 | 7.21 | 5.99 | 3.22 | 7.19 | 5.30 | 6.03 | 2.88 | 15.39 | 12.99 | 16.09 | 3.25 |
Dividend Payout % | 53% | 41% | 46% | 56% | 144% | 74% | 101% | 100% | 348% | 65% | 77% | 6% |
Compounded Sales Growth | |
---|---|
10 Years: | 1% |
5 Years: | -9% |
3 Years: | -22% |
TTM: | -55% |
Compounded Profit Growth | |
---|---|
10 Years: | 11% |
5 Years: | 27% |
3 Years: | 74% |
TTM: | -93% |
Stock Price CAGR | |
---|---|
10 Years: | 9% |
5 Years: | 1% |
3 Years: | -8% |
1 Year: | -2% |
Return on Equity | |
---|---|
10 Years: | 9% |
5 Years: | 10% |
3 Years: | 15% |
Last Year: | 17% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 89 | 86 | 86 | 86 | 101 | 102 | 102 | 153 | 153 | 153 | 150 | 150 | 150 |
Reserves | 3,269 | 3,222 | 3,438 | 7,661 | 7,567 | 7,867 | 7,870 | 7,871 | 7,633 | 8,048 | 6,918 | 7,380 | 7,510 |
2,038 | 1,420 | 1,377 | 1,650 | 930 | 1,122 | 1,638 | 1,112 | 1,329 | 1,778 | 617 | 1,852 | 2,795 | |
1,620 | 2,355 | 2,739 | 2,362 | 2,749 | 2,959 | 4,293 | 4,692 | 6,168 | 9,654 | 10,259 | 7,539 | 6,898 | |
Total Liabilities | 7,016 | 7,083 | 7,639 | 11,759 | 11,347 | 12,050 | 13,903 | 13,828 | 15,283 | 19,633 | 17,944 | 16,921 | 17,353 |
1,350 | 1,572 | 1,649 | 5,397 | 5,116 | 4,902 | 4,981 | 5,354 | 5,598 | 5,477 | 4,319 | 738 | 727 | |
CWIP | 236 | 118 | 370 | 209 | 272 | 663 | 889 | 886 | 722 | 909 | 867 | 118 | 89 |
Investments | 904 | 671 | 873 | 588 | 593 | 594 | 1,441 | 1,406 | 1,441 | 2,374 | 3,208 | 3,513 | 3,683 |
4,525 | 4,721 | 4,747 | 5,565 | 5,366 | 5,891 | 6,592 | 6,182 | 7,522 | 10,873 | 9,550 | 12,552 | 12,854 | |
Total Assets | 7,016 | 7,083 | 7,639 | 11,759 | 11,347 | 12,050 | 13,903 | 13,828 | 15,283 | 19,633 | 17,944 | 16,921 | 17,353 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
190 | 1,139 | 497 | -63 | 1,021 | 497 | 664 | 1,773 | 1,820 | 2,349 | 1,667 | -411 | |
-63 | -84 | -131 | 364 | 268 | -305 | -439 | -435 | -1,175 | -1,481 | 1,210 | 94 | |
-21 | -1,199 | -459 | -322 | -1,295 | -158 | -241 | -1,277 | -502 | -643 | -2,689 | 325 | |
Net Cash Flow | 105 | -144 | -93 | -21 | -6 | 34 | -16 | 61 | 143 | 225 | 188 | 8 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 167 | 104 | 97 | 114 | 103 | 101 | 115 | 120 | 130 | 124 | 231 | 152 |
Inventory Days | 105 | 120 | 152 | 156 | 137 | 135 | 133 | 86 | 113 | 108 | 99 | 30 |
Days Payable | 160 | 188 | 222 | 212 | 220 | 219 | 202 | 216 | 259 | 238 | 396 | 125 |
Cash Conversion Cycle | 113 | 35 | 27 | 57 | 19 | 18 | 47 | -10 | -16 | -7 | -66 | 57 |
Working Capital Days | 176 | 75 | 57 | 100 | 75 | 78 | 66 | 37 | 32 | 33 | 17 | 64 |
ROCE % | 7% | 16% | 13% | 10% | 7% | 8% | 7% | 9% | 8% | 17% | 10% | 13% |
Documents
Announcements
-
Corporate Action - Record For Rights Issue
1d - Approval of rights issue for ₹ 3,377.74 crore.
-
Announcement under Regulation 30 (LODR)-Raising of Funds
1d - Approval of rights issue for ₹ 3,377.74 crore.
-
Board Meeting Outcome for Outcome Of Rights Issue Committee Meeting.
1d - Approval of rights issue for ₹ 3,377.74 crore.
-
Announcement under Regulation 30 (LODR)-Diversification / Disinvestment
2d - UPL sells 8.93% stake in Advanta for $250Mn.
-
Announcement under Regulation 30 (LODR)-Press Release / Media Release
2d - UPL secures $350 million investment in Advanta.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2012
from nse
-
Financial Year 2011
from bse
Concalls
-
Nov 2024Transcript PPT
-
Aug 2024Transcript PPT
-
May 2024Transcript PPT
-
Feb 2024Transcript PPT
-
Jan 2024TranscriptNotesPPTREC
-
Nov 2023Transcript PPT
-
Aug 2023Transcript PPT
-
May 2023Transcript PPT
-
Jan 2023Transcript PPT
-
Nov 2022Transcript PPT
-
Oct 2022TranscriptNotesPPT
-
Aug 2022Transcript PPT
-
May 2022Transcript PPT
-
Jan 2022Transcript PPT
-
Oct 2021Transcript PPT
-
Jul 2021Transcript PPT
-
May 2021Transcript PPT
-
Jan 2021Transcript PPT
-
Oct 2020Transcript PPT
-
Jul 2020Transcript PPT
-
May 2020TranscriptNotesPPT
-
Feb 2020Transcript PPT
-
Nov 2019Transcript PPT
-
Aug 2019TranscriptPPT
-
Feb 2019TranscriptPPT
-
Oct 2018Transcript PPT
-
Aug 2018Transcript PPT
-
Feb 2018TranscriptPPT
-
Nov 2017TranscriptPPT
Business Overview
UPL is a leading provider of agricultural solutions and services, with 14,000+ product registrations, a presence in ~140 countries, access to 90% of the world’s food basket. The products include Crop Protection Chemicals like Insecticides, Fungicides, Herbicides etc. also Seeds, Biosolutions. It is a 5th largest Agrochemical company globally with 43 manufacturing facilities across the globe.[1] [2]